Find
News Releases
= add release to Briefcase
| All Releases | |||
|---|---|---|---|
 |
Conor Medsystems, LLC Reports COSTAR II Pivotal Drug-Eluting Stent Trial Conclusions May 7, 2007 |
11.0 KB |
|
|
MENLO PARK, Calif., May 7, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Citing issues related to potentially sub-optimal therapeutic dosing of paclitaxel, Conor Medsystems, LLC has concluded that the COSTAR II (CObalt Chromium STent with Antiproliferative for Restenosis) trial, the pivotal study for the CoStar(R) cobalt chromium paclitaxe... |
|||
|
Ortho-Clinical Diagnostics, Inc. Issues Voluntary, Nationwide Recall for Cardiac Marker May 4, 2007 |
8.1 KB |
|
|
RARITAN, N.J., May 4, 2007 /PRNewswire via COMTEX News Network/ -- Ortho-Clinical Diagnostics, Inc. has initiated a voluntary, nationwide recall of two lots of a diagnostic test used by physicians to aid in the diagnosis of injury to heart muscle and/or heart attack because of shifts in test results that could contribute to a missed diagnosis of my... |
|||
|
Johnson & Johnson to Participate in Morgan Stanley Conference Apr 27, 2007 |
6.4 KB |
|
|
NEW BRUNSWICK, N.J., April 27, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Johnson & Johnson will participate in The Morgan Stanley Global Healthcare Unplugged Conference, on Friday, May 4th at The Ritz-Carlton, Key Biscayne, Florida. Dominic Caruso, Vice President, Finance and Chief Financial Officer for Johnson & Johnson will represent... |
|||
|
Johnson & Johnson Announces Dividend Increase of 10.7% Apr 26, 2007 |
6.5 KB |
|
|
NEW BRUNSWICK, N.J., April 26, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a 10.7% increase in the quarterly dividend rate, from $.375 per share to $.415 per share. The increase was announced this morning at the Annual Shareholders Meeting in New Bruns... |
|||
|
Johnson & Johnson to Host Annual Meeting of Shareholders Apr 19, 2007 |
6.6 KB |
|
|
NEW BRUNSWICK, N.J., April 19, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Johnson & Johnson will host its Annual Meeting of shareholders at 10 a.m. (Eastern Daylight Time) on Thursday, April 26, at the Hyatt Regency Hotel in New Brunswick, NJ. Investors and other interested parties may access the meeting by visiting the Company's we... |
|||
|
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Breaks Ground on New Facility Apr 19, 2007 |
9.6 KB |
|
|
SPRING HOUSE, Pa., April 19, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) announced today it has started construction of a new building on its Spring House, Pennsylvania campus, that will add approximately 150,000 square feet in new laboratory, clinical development a... |
|||
|
Johnson & Johnson Reports 2007 First-Quarter Results: Sales Increase of 15.7% and EPS of $.88 Versus $1.10 a Year Ago; Excluding Special Items, EPS was $1.16, an increase of 17.2% * Apr 17, 2007 |
24.4 KB |
|
|
NEW BRUNSWICK, N.J., April 17, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Johnson & Johnson today announced record first-quarter sales of $15.0 billion, an increase of 15.7% as compared to the first quarter of 2006. Operational growth was 13.3% with a positive currency impact of 2.4%. Domestic sales were up 11.9%, while international sa... |
|||
|
Johnson & Johnson to Host Analyst Conference Call on First-Quarter Results Apr 11, 2007 |
6.6 KB |
|
|
NEW BRUNSWICK, N.J., April 11, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Johnson & Johnson (NYSE: JNJ) will host a conference call for financial analysts at 8:30 a.m. EDT on Tuesday, April 17, 2007, to review first-quarter results. Dominic Caruso, Vice President, Finance and Chief Financial Officer, and Louise Mehrotra, Vice President,... |
|||
|
Two-Year Patient Registry Results Support Safety and Efficacy of CYPHER(R) Sirolimus-Eluting Coronary Stent in 'Real World' Uses Mar 26, 2007 |
10.9 KB |
|
|
NEW ORLEANS, March 26, 2007 /PRNewswire via COMTEX News Network/ -- A large patient registry of "real world" uses for the CYPHER(R) Sirolimus-eluting Coronary Stent reported favorable safety and efficacy outcomes at two-year follow-up, according to clinical investigators at the American College of Cardiology's 56th Annual Scientific Session (ACC.07... |
|||
|
Cordis Corporation to Emphasize Commitment to Interventional Cardiology at ACC.07 Mar 20, 2007 |
12.5 KB |
|
|
MIAMI LAKES, Fla., March 20, 2007 /PRNewswire via COMTEX News Network/ -- Cordis Corporation will highlight its commitment to the practice of interventional cardiology at the upcoming American College of Cardiology's 56th Annual Scientific Session (ACC.07) in New Orleans from March 24-27. During this worldwide medical conference, cardiologists ... |
|||
|
Johnson & Johnson to Participate in Lehman Brothers Tenth Annual Global Healthcare Conference Mar 13, 2007 |
6.3 KB |
|
|
NEW BRUNSWICK, N.J., March 13, 2007 /PRNewswire via COMTEX News Network/ -- Johnson & Johnson will participate in the Tenth Annual Lehman Brothers Global Healthcare Conference on Tuesday, March 20th at the Loews Miami Beach Hotel in Miami, Florida. Christine Poon, Vice Chairman, Board of Directors, will represent the Company in a session scheduled ... |
|||
|
Johnson & Johnson Receives Subpoenas Mar 12, 2007 |
6.2 KB |
|
|
NEW BRUNSWICK, N.J., March 12, 2007 /PRNewswire via COMTEX News Network/ -- Johnson & Johnson (NYSE: JNJ) today announced that it has received separate subpoenas from the U.S. Attorney's Office in Philadelphia, the U.S. Attorney's Office in Boston and the U.S. Attorney's Office in San Francisco. The subpoenas relate to investigations by those three... |
|||
|
Johnson & Johnson to Participate in the 27th Annual Cowen & Company Health Care Conference Mar 7, 2007 |
6.4 KB |
|
|
NEW BRUNSWICK, N.J., March 7, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Johnson & Johnson will participate in the 27th Annual Cowen & Company Health Care Conference on Tuesday, March 13th at the Boston Marriott Copley Place Hotel in Boston, Massachusetts. Dominic Caruso, Corporate Vice President, Finance and Chief Financial Officer, wi... |
|||
|
Johnson & Johnson Statement on Voluntary Disclosure Feb 12, 2007 |
6.3 KB |
|
|
NEW BRUNSWICK, N.J., Feb 12, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Johnson & Johnson today voluntarily disclosed to the U.S. Department of Justice (DOJ) and the U.S. Securities and Exchange Commission (SEC) that subsidiaries outside the United States are believed to have made improper payments in connection with the sale of medical... |
|||
|
Johnson & Johnson Completes Acquisition of Conor Medsystems, Inc. Feb 1, 2007 |
6.7 KB |
|
|
NEW BRUNSWICK, N.J., Feb 01, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Johnson & Johnson (NYSE: JNJ) today announced the closing of its previously announced acquisition of Conor Medsystems, Inc., a cardiovascular device company with a unique controlled drug delivery technology. "The completion of the acquisition of Conor Medsystems... |
|||
|
Johnson & Johnson Reports Fourth-Quarter and Full-Year 2006 Results Jan 23, 2007 |
19.7 KB |
|
|
NEW BRUNSWICK, N.J., Jan 23, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Johnson & Johnson today announced record sales of $13.7 billion for the fourth quarter of 2006, an increase of 8.5% as compared to the fourth quarter of 2005. Operational growth was 6.2% with a positive currency impact of 2.3%. Domestic sales were up 6.4%, while int... |
|||
|
Johnson & Johnson to Review Fourth-Quarter and Full-Year 2006 Financial Results Jan 17, 2007 |
6.7 KB |
|
|
NEW BRUNSWICK, N.J., Jan 17, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Johnson & Johnson will hold a meeting for financial analysts at 8:30 a.m. ET on Tuesday, January 23, 2007 to review fourth-quarter and full-year 2006 financial results. William C. Weldon, Chairman and Chief Executive Officer, will host the meeting. Investors... |
|||
|
Johnson & Johnson Completes Acquisition of Pfizer Consumer Healthcare Dec 20, 2006 |
8.2 KB |
|
|
NEW BRUNSWICK, N.J., Dec 20, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Johnson & Johnson (NYSE: JNJ) today announced the closing of its previously announced acquisition of Pfizer Consumer Healthcare for $16.6 billion in cash. "The completion of the Pfizer Consumer Healthcare acquisition builds upon our broad base in health products... |
|||
|
Johnson & Johnson Acquisition of Pfizer Consumer Healthcare Receives Clearance from U.S. Federal Trade Commission (FTC) Dec 12, 2006 |
7.5 KB |
|
|
NEW BRUNSWICK, N.J., Dec 12, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Federal Trade Commission (FTC) has cleared the Company's proposed acquisition of Pfizer Consumer Healthcare. In addition to FTC clearance, Johnson & Johnson also received clearance from The European Commiss... |
|||
|
Analysis From Real-World Drug Administration Data Suggests Lower Drug Cost For PROCRIT(R) (Epoetin Alfa) in Outpatient Setting Dec 11, 2006 |
10.3 KB |
|
|
ORLANDO, Fla., Dec 11, 2006 /PRNewswire via COMTEX News Network/ -- An analysis of observational data from real-world clinical practice suggests PROCRIT(R) (Epoetin alfa) has a lower drug cost in the outpatient setting when treating chemotherapy-induced anemia, compared with darbepoetin alfa, another drug in the same class.(1) Based on the average ... |
|||
= add release to Briefcase
